Diabetes and mental illness: improving outcomes and services (DIAMONDS)


Lead: Dr Najma Siddiqi (N.Siddiqi@leeds.ac.uk)

Project Co-ordinator: Dr Jo Taylor (jo.taylor@york.ac.uk)

Collaborators: Ramzi Ajjan, Shehzad Ali, Sara Alderson, Tim Doran, Tricia Gallagher, Simon Gilbody , Suzanne Heywood-Everett, Cath Hewitt, Tom Hughes, Sarah Kirkland, Helen Lewis, Neda Mahmoodi, K.J.McDermid, Steve Parrott, Robert Smith, Brendon Stubbs, Judy Wright

Background:

People with severe mental illness (SMI) die approximately 20 years earlier than the general population. People with diabetes also die earlier. A 60-year old male newly diagnosed with type 2 diabetes without pre-existing cardiovascular disease can expect to lose 8 to 10 years of life if his diabetes is poorly controlled (National Collaborating Centre 2008). Having diabetes & SMI compounds problems of both. Diabetes is more than twice as prevalent in people who suffer from SMI and have poorer outcomes compared to people without. Reasons for this are poorly understood, but are probably related to a combination of features of the mental illness, metabolic side effects of psychotropic medication and the organisation of health services.

 


The DIAMONDS programme:

A programme of work is being undertaken between Bradford District Care Trust, the University of York and the University of Leeds, supported by NIHR CLAHRC Yorkshire and Humber, with the aim of improving the healthcare of people with SMI and diabetes. We will be working closely, not only with our own academic team, but with stakeholders and a newly formed Patient and Public Involvement (PPI) group. Further information about our PPI group can be obtained from Sarah Kirkland Sarah.Kirkland@bdct.nhs.uk)


Phase One: We will concentrate on developing an in- depth picture of people with SMI and diabetes, describing their health status and the care they receive. We will also look at the barriers and facilitators to good healthcare for people with SMI and diabetes, and what types of care have been tested in this area. We will do this by conducting three studies:

·         Interrogation of large health service datasets in primary and secondary care

·         Comprehensive and Systematic reviews of the literature

·         Qualitative interviews with patients, carers and healthcare providers

Phase Two: These three strands of work will inform the development of better care for people with SMI and diabetes in the future. We will then test whether this is feasible to trial and implement.

Phase Three: To evaluate a newly developed method of healthcare for people with SMI and diabetes. This will result in a full multi-centred Randomised controlled trial with a process evaluation and evaluation of the effectiveness and cost effectiveness of a new method of care.